Pedro Nonato da Silva Júnior

Mr. Pedro Nonato da Silva Júnior

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Toxicon
Verified
Journal Article
Closed access
PJPedro Nonato da Silva Júnior
Pedro Nonato da Silva Júnior
JNJoão Victor Serra Nunes
João Victor Serra Nunes
BDBruna Ribeiro Duque
Bruna Ribeiro Duque
APAna Júlia Batista Pereira
Ana Júlia Batista Pereira
EMEmanuel Paula Magalhães
Emanuel Paula Magalhães
AMAlice Maria Costa Martins
Alice Maria Costa Martins

7 May 2026 in Biophysica
Verified
Journal Article
Open access
PDF file
EBEveline Bezerra
Eveline Bezerra
PJPedro Nonato da Silva Júnior
Pedro Nonato da Silva Júnior
TSTaciano Amaral Sorrentino
Taciano Amaral Sorrentino
FSFrancisco A. M. Sales
Francisco A. M. Sales
AMAlice Maria Costa Martins
Alice Maria Costa Martins
RCRoner Ferreira da Costa
Roner Ferreira da Costa
Chagas disease remains a major neglected parasitic illness in Latin America and other endemic regions, and benznidazole (BZN) is still the primary trypanosomacidal drug despite its incompletely understood mechanism of action. This work provides a detailed biophysical characterization of the conformational behavior and vibrational properties of benznidazole (BZN), a first-line trypanocidal drug still widely used for the treatment of Chagas disease. Using density functional theory combined with relaxed potential energy surface scans in vacuum and implicit water, two low-energy conformers (BZN1 and BZN2) were identified, separated by moderate rotational barriers and a small energy difference, indicating that both are intrinsically accessible at room temperature. For each conformer, infrared and Raman spectra were calculated and assigned via vibrational mode analysis, then compared with FT-IR and FT-Raman spectra recorded for pharmaceutical-grade polycrystalline BZN. The theoretical and experimental spectra show excellent agreement, with a Raman band in the 1350–1400 cm−1 region emerging as a sensitive conformational marker: the experimental maximum at 1359cm−1 matches the most intense BZN1 mode, whereas the corresponding BZN2 band appears about 13cm−1 higher in frequency. This clear spectroscopic fingerprint demonstrates that the solid drug is overwhelmingly composed of the BZN1 conformer, despite the theoretical accessibility of BZN2. Overall, the study links the conformational landscape of benznidazole to its vibrational signatures and highlights Raman spectroscopy, supported by quantum chemical calculations, as a powerful tool for conformational and potential polymorphic control of this clinically important nitroimidazole.

2 January 2026 in Journal of Health & Biological Sciences
Verified
Journal Article
Open access
PDF file
RFRejane Moraes Falcão
Rejane Moraes Falcão
APAna Júlia Batista Pereira
Ana Júlia Batista Pereira
NPNatasha Maria Lima Pinheiro
Natasha Maria Lima Pinheiro
PJPedro Nonato da Silva Júnior
Pedro Nonato da Silva Júnior
ÍMÍtalo Costa Monteiro
Ítalo Costa Monteiro
TSTiago Sampaio
Tiago Sampaio
Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.